FosunPharma to Spend $73.5 Million on Global Technology Incubator Jul 11, 2017 Life Science, Technology
Resverlogix Randomizes First Patient in Taiwan/China Portion of the Phase 3 BETonMACE Clinical Trial Jul 11, 2017 Life Science, Technology
BeiGene Initiates Pivotal Trial of PD-1 Antibody BGB-A317 in China in Patients with Urothelial Cancer Jul 6, 2017 Life Science
DelMar Pharmaceuticals Joins National Brain Tumor Society’s Research Roundtable Jun 30, 2017 Life Science
Resverlogix Announces Fourth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone Jun 29, 2017 Life Science
AGIC Capital To Acquire US Pharmaceutical Firm Ritedose For Asian Expansion Jun 26, 2017 Life Science
DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM Jun 23, 2017 Life Science
Chi-Med Initiates a Phase I/II Clinical Trial of Novel FGFR Inhibitor HMPL 453 in China Jun 22, 2017 Life Science
DelMar Presents Poster of Clinical Research with VAL-083 in Patients with Chemo-resistant Glioblastoma (“GBM”) at SNO’s Pediatric Neuro-Oncology Basic and Translational Research Conference Jun 17, 2017 Life Science
RedHill Biopharma Announces Confirmatory Phase III Study Initiated with RHB-105 (TALICIA™) for H. pylori Infection Jun 15, 2017 Life Science